Scotland business

Aberdeen's Wood Group wins pharmaceutical deal in Germany

Energy services giant Wood Group has secured a major contract which sees it build on its move into the pharmaceutical sector.

The Aberdeen-based firm is to take charge of building a new biotechnology plant for GlaxoSmithKline in Marburg, Germany.

The multi-million pound contract will see a division of Wood Group design and project manage the construction of the new meningitis vaccine factory.

It is due to be completed in July 2019.

The contract builds on a relationship Wood Group began 12 years ago with the vaccines division of GSK.

Wood Group's chief executive Robin Watson said the contract shows GSK's confidence in the company's global capabilities.

More on this story

Related Internet links

The BBC is not responsible for the content of external Internet sites